Contribute Try STAT+ Today

Good morning, everyone, and nice to see you again after we took an extended break. We hope the weekend respite was relaxing and invigorating. Certainly, it was interesting to watch the much-ballyhooed space tourism industry get a lift, of sorts. How many of you have booked a flight? As for us, we are coping with more earthly matters, such as our to-do list. No doubt, you can relate. So here are a few tidbits to get you going. Hope all goes well today, and do keep in touch. …

Pfizer (PFE) is expected to brief top U.S. government health officials Monday about the need for a Covid-19 vaccine booster shot after an unusual public spat between the company and federal officials over whether a third shot will be necessary, The Washington Post reports. Pfizer and BioNTech (BNTX) plan to seek regulatory approval for a booster within weeks because they anticipate people would need a third dose six to 12 months after receiving the two-shot regimen. But top U.S. health officials have not decided whether boosters will be necessary.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment